Stock Movers Novo Nordisk Sinks, Domino's Pizza Rises, International Paper Falls on Surprise Price Drop
Feb 23, 2026
A biotech trial shakes up shares after a next-generation obesity drug trails a rival in head-to-head results. A pizza chain posts stronger-than-expected comparable sales as pricing and fees boost revenue. A packaging maker tumbles on a surprise containerboard price drop that analysts say could pressure sector earnings.
AI Snips
Chapters
Transcript
Episode notes
Novo Nordisk Stock Drops After Head-to-Head Trial
- Novo Nordisk shares plunged after its next-gen obesity shot CagriSema lost a head-to-head trial versus Eli Lilly’s tirzepatide.
- Alexis Christophorus notes the stock is down 54% over the past year and fell another 14% today on the trial results and analyst downgrades.
Domino's Sales Beat Driven By Volume And Fees
- Domino's Pizza beat revenue expectations with stronger comparable sales driven by selling more food and higher ingredient prices.
- Alexis Christophorus says Domino's also collected more franchise fees and is taking modest U.S. market share from competitors.
International Paper Hurt By Unexpected Containerboard Price Drop
- International Paper shares plunged after a surprise $20/ton drop in U.S. containerboard prices due to weak demand and rising European imports.
- J.P. Morgan warned the unexpected decline hurts earnings outlooks across U.S. packaging firms.